Back to top
more

Teladoc Health (TDOC)

(Delayed Data from NYSE)

$9.23 USD

9.23
3,854,988

-0.28 (-2.94%)

Updated Nov 8, 2024 04:00 PM ET

After-Market: $9.27 +0.04 (0.43%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth F Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 45% (138 out of 251)

Industry: Medical Services

Zacks News

Teladoc Health Q3 Loss Narrows on Strong Integrated Care Unit

TDOC expects 2024 U.S. Integrated Care Members to remain within 93.5-94.5 million.

Teladoc (TDOC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for Teladoc (TDOC) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Teladoc (TDOC) Reports Q3 Loss, Tops Revenue Estimates

Teladoc (TDOC) delivered earnings and revenue surprises of 34.48% and 1.59%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Exploring Analyst Estimates for Teladoc (TDOC) Q3 Earnings, Beyond Revenue and EPS

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Teladoc (TDOC), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2024.

Teladoc (TDOC) Stock Dips While Market Gains: Key Facts

The latest trading day saw Teladoc (TDOC) settling at $8.60, representing a -0.92% change from its previous close.

Strength Seen in MultiPlan (MPLN): Can Its 9.0% Jump Turn into More Strength?

MultiPlan (MPLN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Teladoc (TDOC) Stock Sinks As Market Gains: Here's Why

Teladoc (TDOC) reachead $8.41 at the closing of the latest trading day, reflecting a -0.71% change compared to its last close.

Teladoc Stock Rises 12% as Jefferies Boosts Price Target on BetterHelp

TDOC's stock benefits from improving web traffic in its BetterHelp platform.

Why Teladoc (TDOC) Outpaced the Stock Market Today

Teladoc (TDOC) closed at $8.16 in the latest trading session, marking a +0.87% move from the prior day.

Why Teladoc (TDOC) Outpaced the Stock Market Today

Teladoc (TDOC) closed at $7.25 in the latest trading session, marking a +0.83% move from the prior day.

Teladoc Stock Near 52-Week Low: Is it Healthy Enough to Invest?

TDOC is well positioned to grow in the long run on the back of expanding product offerings, memberships, AI integration, business diversification and global expansions.

Debanjana Dey headshot

Hims & Hers Stock Plunges 32.1% in Three Months: What's Next?

HIMS is enhancing its offerings and expanding the breadth of health and wellness products and services. However, macro challenges are likely to hurt its performance.

Here's Why Teladoc (TDOC) Gained But Lagged the Market Today

In the closing of the recent trading day, Teladoc (TDOC) stood at $7.17, denoting a +0.99% change from the preceding trading day.

Masimo's (MASI) W1 Watch Gains FDA Nod for SafetyNet Connectivity

The latest FDA clearance of Masimo's (MASI) W1 medical watch is likely to provide a continuous and accurate view of patients' health data.

Debanjana Dey headshot

Hims & Hers (HIMS) Gains 45.8% in Three Months: What's Next?

Hims & Hers (HIMS) is enhancing its offerings and expanding the breadth of health and wellness products and services. However, macro challenges are likely to hurt its performance.

Teladoc Health (TDOC) Shares Down 8.9% Despite Q2 Earnings Beat

Teladoc Health (TDOC) expects revenue growth in the Integrated Care segment to be within low to mid-single-digit growth in 2024, on a year-over-year basis.

Teladoc (TDOC) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

Although the revenue and EPS for Teladoc (TDOC) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Teladoc (TDOC) Reports Q2 Loss, Misses Revenue Estimates

Teladoc (TDOC) delivered earnings and revenue surprises of 22.22% and 1.06%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Can Teladoc (TDOC) Q2 Earnings Navigate BetterHelp Profit Woes?

Teladoc's (TDOC) second-quarter results are likely to reflect lower advertising and marketing expenses.

Countdown to Teladoc (TDOC) Q2 Earnings: Wall Street Forecasts for Key Metrics

Beyond analysts' top -and-bottom-line estimates for Teladoc (TDOC), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2024.

Teladoc (TDOC) Ascends While Market Falls: Some Facts to Note

Teladoc (TDOC) closed the most recent trading day at $9.30, moving +1.2% from the previous trading session.

Teladoc (TDOC) Ascends But Remains Behind Market: Some Facts to Note

Teladoc (TDOC) closed the most recent trading day at $9.39, moving +0.21% from the previous trading session.

Debanjana Dey headshot

Hims & Hers (HIMS) Gains 37.7% in Three Months: What's Next?

Hims & Hers (HIMS) is enhancing its offerings and expanding the breadth of health and wellness products and services. However, macro challenges are likely to hurt its performance.

Teladoc (TDOC) Stock Declines While Market Improves: Some Information for Investors

Teladoc (TDOC) closed at $10.14 in the latest trading session, marking a -0.1% move from the prior day.

Teladoc (TDOC) Harnesses AI for Diabetes Care, Stock Rises 6.7%

AI can help Teladoc (TDOC) to streamline healthcare delivery, making it more efficient and scalable.